Disclosure Statements

[vc_row type=”in_container” scene_position=”center” text_color=”dark” text_align=”left” overlay_strength=”0.3″][vc_column column_padding=”no-extra-padding” column_padding_position=”all” background_color_opacity=”1″ background_hover_color_opacity=”1″ width=”1/1″][vc_column_text]

The Global Initiative for Asthma (GINA)
Disclosure Statements

[/vc_column_text][/vc_column][/vc_row][vc_row type=”in_container” scene_position=”center” text_color=”dark” text_align=”left” overlay_strength=”0.3″][vc_column column_padding=”no-extra-padding” column_padding_position=”all” background_color_opacity=”1″ background_hover_color_opacity=”1″ width=”1/2″][vc_column_text]

GINA Committee members disclose relationships (personal benefits, shares, and non-personal interests) with profit-making organizations in December of each year using the following definitions:

  • Personal Benefits (Consultancy-Lecture Fees) refers to fees for lectures, advisory committees or consultancy services either intermittent or regular, from which a GINA member benefits personally. This includes ongoing attendance at advisory board meetings but would not normally include a situation where an individual is paid for a specific item or for attending or speaking at an occasional meeting.
  • Shares refers to any shares in the pharmaceutical industry, excluding unit trusts, pension plans or mutual funds, and it refers to shares held by a GINA member or family members (spouse/children). The company is to be listed, not the number of shares.
  • Non-Personal Interests refers to fees or grants paid to a GINA Committee member (or the Department/Institution on behalf of a GINA member) and used for research, education, equipment, salaries, etc.

[/vc_column_text][/vc_column][vc_column column_padding=”no-extra-padding” column_padding_position=”all” background_color_opacity=”1″ background_hover_color_opacity=”1″ width=”1/2″][tabbed_section style=”default” alignment=”left”][tab title=”Board of Directors Disclosures” tab_id=”1525791311212-1″ id=”1525791418966-1″][vc_column_text]2017 GINA Disclosure_Jan2018_Reddel

2017 GINA Disclosure_A. Cruz

2017 GINA Disclosure EBateman

2017 GINA Disclosure Yorgancioglu

2017 GINA Disclosure-Levy

2017 GINA DisclosureBoard Pedersen

GINA.FitzGerald.COI.2017.2018

2017 GINA Disclosure Boulet

2017 GINA Disclosure Lin[/vc_column_text][/tab][tab title=”Science Committee Disclosures” tab_id=”1525791311328-0″ id=”1525791396498-5″][vc_column_text]2017 GINA Disclosure_Jan2018_Reddel

2017 GINA Disclosure Ko

2017 GINA Disclosure_Buhl

GINA.FitzGerald.COI.2017.2018

2017 GINA Disclosure_Jan2018_Reddel

2017 GINA DisclosureScience Pedersen

GINA Disclosure 2017 Becker

2017 GINA Disclosure Bacharier

2018 GINA Disclosure de Jongste

2017 GINA Disclosure EBateman[/vc_column_text][/tab][/tabbed_section][/vc_column][/vc_row]